Pancreas Ultrasound Imaging in type1 Diabetes

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Type1diabetesInsulitisPancreas Inflamed
Interventions
DRUG

Definity Suspension for Injection

"* DEFINITY is administered as per manufactures instructions~* 1 vial of DEFINITY is allowed to warm to room temperature and activated by 45s shaking on a VIALMIX~* Withdraw the activated milky white suspension using the provided Dispensing Pin, PINSYNC or 18-20 gauge syringe needle, from the middle of the liquid in the inverted vial.~* Deliver a dose of 10 μl/kg of 'milky white suspension' IV as a bolus, delivered over 30seconds.~* Following imaging, provide a 10 mL flush of preservative-free saline~* Wait at least 30minutes until second dose (if provided)."

Trial Locations (1)

80045

RECRUITING

University of Colorado Anschutz, Barbara Davis Center, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER